Restricting α-Synuclein Transport into Mitochondria by Inhibition of α-Synuclein-VDAC Complexation as a Potential Therapeutic Target for Parkinson's Disease Treatment
M. Rajendran, M. Queralt-Martin, P. A. Gurnev, W. M. Rosencrans, A. Rovini, D. Jacobs, K. Abrantes, D. P. Hoogerheide, S. M. Bezrukov, T. K. Rostovtseva
This study shows that a peptide from hexokinase 2 inhibits alpha-synuclein-VDAC complexation, reducing alpha-synuclein mitochondrial translocation and toxicity in Parkinson's disease.
bioRxiv · Apr 7, 2022Biophysics